National Cancer Institute (U.S.), Division of Cancer Cause and Prevention
Label
National Cancer Institute (U.S.), Division of Cancer Cause and Prevention
Name
National Cancer Institute (U.S.)
Subordinate unit
Division of Cancer Cause and Prevention
Actions
Incoming Resources
- Bioassay of 1-phenyl-3-methyl-5-pyrazolone for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 5-nitro-o-toluidine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of ethionamide for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of dibromochloropropane for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2,3,5,6-tetrachloro-4-nitroanisole for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 4-chloro-m-phenylenediamine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of pentachloronitrobenzene for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of n-phenyl-p-phenylenediamine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of p-anisidine hydrochloride for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2-aminoanthraquinone for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of o-anisidine hydrochloride for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of phenesterin for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of fenthion for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of endrin for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of diarylanilide yellow for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of triphenyltin hydroxide for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of C.I. vat yellow 4 for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of picloram for possible carcinogenicity, Carcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of phosphamidon for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of m-cresidine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of sulfallate for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of p-cresidine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of (2-chloroethyl) trimethylammonium chloride for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 5-nitroacenaphthene for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of tolazamide for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of malathion for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of captan for possible carcinogenicity, Carcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health ; prepared at Tracor Jitco
- Bioassay of acetohexamide for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of estradiol mustard for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 5-azacytidine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of hydrazobenzene for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of butylated hydroxytoluene (BHT) for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2,4,5-trimethylaniline for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of ethyl tellurac for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2-amino-5-nitrothiazole for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2,5-toluenediamine sulfate for possible carcinogenicity
- Bioassay of chloropicrin for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 2,7-dichlorodibenzo-p-dioxin (DCDD) for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of Aroclor® 1254 for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of emetine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of ICRF-159 for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of parathion for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 1,5-naphthalenediamine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of trimethylthiourea for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of 1-nitronaphthalene for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of procarbazine for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of photodieldrin for possible carcinogenicity, Carcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Healh ; prepared at Tracor Jitco
- Bioassay of 3-amino-9-ethylcarbazole (hydrochloride) for possible carcinogenicity
- Bioassay of 3-nitropropionic acid for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of health
- Bioassay of phenoxybenzamine hydrochloride for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- inverse.issuingbody2
- Bioassay of 1-phenyl-3-methyl-5-pyrazolone for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
- Bioassay of phthalic anhydride for possible carcinogenicity, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health